Drug Type Small molecule drug |
Synonyms Oxycodone hydrochloride (USP), Oxycodone Hydrochloride Hydrate, ATLP-02 + [32] |
Target |
Action agonists |
Mechanism Opioid receptors agonists(Opioid receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date United States (26 Oct 1998), |
Regulation- |
Molecular FormulaC18H22ClNO4 |
InChIKeyMUZQPDBAOYKNLO-RKXJKUSZSA-N |
CAS Registry124-90-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00847 | Oxycodone Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Cancer Pain | Japan | 01 May 2012 | |
Acute Pain | China | 21 Jan 2004 | |
Chronic Pain | China | 21 Jan 2004 | |
Pain | United States | 26 Oct 1998 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Low Back Pain | Phase 3 | United States | 01 Mar 2016 | |
Osteoarthritis, Spine | Phase 3 | United States | 01 Apr 2004 | |
Analgesia | Phase 1 | United States | 01 Jul 2010 | |
Analgesia | Phase 1 | Australia | 01 Jul 2010 | |
Analgesia | Phase 1 | Finland | 01 Jul 2010 | |
Analgesia | Phase 1 | New Zealand | 01 Jul 2010 |
Phase 4 | 84 | (Preoperative Adductor Canal Block Group) | jcowckhcuy(tvjgmnzudv) = rzickdtqwm aniedhyzdf (msjvgsvweh, bhakdkcszh - tqglupzols) View more | - | 12 Feb 2025 | ||
(Postoperative Adductor Canal Block Group) | jcowckhcuy(tvjgmnzudv) = cpbcbyexts aniedhyzdf (msjvgsvweh, klejwfjvvg - cttyfmsyaj) View more | ||||||
Phase 4 | 3 | (Oxycodone) | bnbnypekqe(yxwzdnvbzo) = yzefvensrx seqeodpjfa (kgnnedthfk, prxojelbze - vusytvbqyr) View more | - | 17 Dec 2024 | ||
(Tapentadol) | bnbnypekqe(yxwzdnvbzo) = ysuzsjycad seqeodpjfa (kgnnedthfk, pdydinubfi - bwdygzdhwg) View more | ||||||
Phase 4 | 48 | (Standard Protocol) | qgjmjibung(prewufzmll) = rhmwtjzakr qcgzxxikip (jucswdpevt, buhelhiigw - rgtklubzns) View more | - | 19 Sep 2024 | ||
(Enhanced Recovery Protocol) | qgjmjibung(prewufzmll) = fdmsywfxdp qcgzxxikip (jucswdpevt, xitrxrdrvf - dimxwfjqwz) View more | ||||||
Phase 1/2 | 73 | (Opioid Pain Control) | ifaxpvrjdz(ecayszxwlq) = lowjnczxfp chvpyzhzjs (ncoqygvjac, rdaaubaoor - ujhrfplfjx) View more | - | 16 Aug 2024 | ||
(Non-opioid Pain Control) | ifaxpvrjdz(ecayszxwlq) = jutarjmvft chvpyzhzjs (ncoqygvjac, dmbgtonwht - euvsmcnjoa) View more | ||||||
Phase 4 | - | 100 | (Multi-modal) | zufkwlfyit(pxfwwprmbq) = wbxluuibpa ciyeavlfri (rxdrgftmkx, pkgkwmjees - oymspzwveb) View more | - | 08 Jul 2024 | |
(Control) | zufkwlfyit(pxfwwprmbq) = aeiifnourd ciyeavlfri (rxdrgftmkx, fjfadtxres - zklsuhwcez) View more | ||||||
Phase 4 | 98 | (Oxycodone Arm) | uqxzquspyv(blftrvfszl) = bayzzppiru wbdzyimbva (hfdlsazknj, esiqoxteiu - kaekhmfxux) View more | - | 11 Oct 2023 | ||
Placebo oral tablet (Placebo Arm) | uqxzquspyv(blftrvfszl) = estaekajds wbdzyimbva (hfdlsazknj, qpslxuybhj - lwccyaovmq) View more | ||||||
Phase 3 | 68 | Paracervical block with ropivacaine+Local anesthetic injection with ropivacaine at abdominal laparoscopic port sites+Hydromorphone+Acetaminophen+Oxycodone+Ketorolac+celecoxib+Gabapentin (Prospective Cohort) | ueotsnthca(zrnmuqldol) = isifrlahwy yxdbqhxhrg (kxbiqcozgk, orietwdmxv - xlgotobisp) View more | - | 01 Aug 2023 | ||
(Historical Control) | ueotsnthca(zrnmuqldol) = yguoujmarb yxdbqhxhrg (kxbiqcozgk, nhnnntzdfu - phnvikhima) View more | ||||||
Phase 4 | - | 22 | gxznerkofl(ojcptmjkop) = fsdbqtrusq bukcpzpoqv (chidzpguwf ) View more | Positive | 21 Jun 2023 | ||
Placebo | gxznerkofl(ojcptmjkop) = pfkuzxytgk bukcpzpoqv (chidzpguwf ) View more |